Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
August 1, 1970
Haemodialysis in the management of chronic renal failure during pregnancy
R J Pepperell, W R Adam, J K Dawborn
Endocrinology
|
May 1, 1979
The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane
S Ulick, D Marver, W R Adam, et al.
Australian and New Zealand Journal of Medicine
|
February 11, 1999
Comorbidities and prediction of length of hospital stay
C J Roe, E Kulinskaya, N Dodich, et al.
Endocrinology
|
August 1, 1978
Amplification of the action of aldosterone by 5 alpha-dihydrocortisol
W R Adam, J W Funder, J Mercer, et al.
The Medical Journal of Australia
|
September 22, 1979
Duration of effect of different diuretics
T O Morgan, W R Adam, N Hodgson, et al.
The Medical Journal of Australia
|
May 12, 1973
The use of sulphadimidine (sulphamezathine) in patients with renal failure
W R Adam, D J Brown, P Hales, et al.
Cardiovascular and Interventional Radiology
|
May 30, 2008
Fibromuscular dysplasia presenting with bilateral renal infarction
O Doody, W R Adam, P T Foley, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1989
Effect of magnesium depletion and potassium depletion and chlorothiazide on intracellular pH in the rat, studied by 31P NMR
W R Adam, D J Craik, M Kneen, et al.
Journal of Steroid Biochemistry
|
May 1, 1976
16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats
P J Fuller, L Pressley, W R Adam, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1983
Cyproheptadine and mineralocorticoid effector mechanisms
D Armanini, G J Goland, W R Adam, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
August 1, 1970
Haemodialysis in the management of chronic renal failure during pregnancy
R J Pepperell, W R Adam, J K Dawborn
Endocrinology
|
May 1, 1979
The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane
S Ulick, D Marver, W R Adam, et al.
Australian and New Zealand Journal of Medicine
|
February 11, 1999
Comorbidities and prediction of length of hospital stay
C J Roe, E Kulinskaya, N Dodich, et al.
Endocrinology
|
August 1, 1978
Amplification of the action of aldosterone by 5 alpha-dihydrocortisol
W R Adam, J W Funder, J Mercer, et al.
The Medical Journal of Australia
|
September 22, 1979
Duration of effect of different diuretics
T O Morgan, W R Adam, N Hodgson, et al.
The Medical Journal of Australia
|
May 12, 1973
The use of sulphadimidine (sulphamezathine) in patients with renal failure
W R Adam, D J Brown, P Hales, et al.
Cardiovascular and Interventional Radiology
|
May 30, 2008
Fibromuscular dysplasia presenting with bilateral renal infarction
O Doody, W R Adam, P T Foley, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1989
Effect of magnesium depletion and potassium depletion and chlorothiazide on intracellular pH in the rat, studied by 31P NMR
W R Adam, D J Craik, M Kneen, et al.
Journal of Steroid Biochemistry
|
May 1, 1976
16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats
P J Fuller, L Pressley, W R Adam, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1983
Cyproheptadine and mineralocorticoid effector mechanisms
D Armanini, G J Goland, W R Adam, et al.
Page
of 9